Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Equillium Inc (EQ)

Equillium Inc (EQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Equillium Inc 2223 Avenida de la Playa Suite 105 LA JOLLA CA 92037 USA

www.equilliumbio.com P: 858-240-1200

Description:

Equillium, Inc. is a biotechnology company. It develops products for autoimmune and inflammatory disorders. The company's product pipeline consists of EQ001 which is in clinical-stage. Equillium, Inc. is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 26,829
Enterprise Value, $K 3,609
Shares Outstanding, K 35,255
Annual Sales, $ 36,080 K
Annual Net Income, $ -13,340 K
Last Quarter Sales, $ 10,690 K
Last Quarter Net Income, $ -2,730 K
EBIT, $ -13,200 K
EBITDA, $ -13,810 K
60-Month Beta 1.82
% of Insider Shareholders 30.30%
% of Institutional Shareholders 27.05%
Float, K 24,573
% Float 69.70%
Short Volume Ratio 0.58

Growth:

1-Year Return -8.54%
3-Year Return -86.41%
5-Year Return -86.19%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 65.14%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 05/09/24
Next Earnings Date 08/14/24
Earnings Per Share ttm -0.36
EPS Growth vs. Prev Qtr -14.29%
EPS Growth vs. Prev Year 27.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

EQ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.20%
Return-on-Assets % -23.31%
Profit Margin % -36.97%
Debt/Equity 0.00
Price/Sales 0.72
Price/Cash Flow N/A
Price/Book 1.19
Book Value/Share 0.60
Interest Coverage -25.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar